Skip to content
Whale Atlas — Follow the signal.
Home
FULL RECORDS
Search insider filingsAll Congress filings
MORE TOOLS
WatchlistGold IntelligencePeopleCharts & technicalsCompany financialsOfficial newsMy saved workspace
YOUR RESEARCH
HomeSearch insider filingsAll Congress filings
More research tools
ExploreGold IntelligencePeopleInvestigate an ideaCharts & technicalsMore evidenceCompany financialsOfficial newsMy research & helpWatchlistMy saved workspaceLearn the basicsHow signals workData & coverage
RESOURCES
LearnMethodologyData sources
Built on public evidence.

Primary sources. Clear reasoning.
No black boxes.

Our approach
Public research workspacev1.0

Loading data…Scanning SEC filings…Checking Congress reports…Following the signal…

HomeSearchCongressWatchlist
© 2026 Whale AtlasFree public-filing research. Not financial advice. By using this site you agree to the Terms of Use.
FAQCompare trackersMethodologyData & correctionsTermsPrivacy
Back to Home
P

PFE

NYSE

PFIZER INC

Latest disclosureOctober 1, 2026
Insider score Why 55?
55/ 100
Qualifying buys · 30d
$0

3 purchases · 2 sales

Price by TradingViewDelayed quote from TradingView, for viewing only. It does not power Whale Atlas scores or alerts. If the quote does not load, open the TradingView link.

Insider transactions 49

Limited filing history
All49Buying3Selling2Other44
Filters

Last 30 daysNo qualifying insider buying. No qualifying insider sales.

44 of 49 trades · March 27, 2026 – September 30, 2026Incomplete history: this shows the filings imported so far, not every filing ever made. Dates are trade dates. Filters affect this table only.

Showing the first 6 of 20 trades on this page.

Award disclosed

Albert Bourla

Chairman & CEO

Phantom Stock Units SSP

Derivative security · not the ordinary share price.

Value context
$598.92
Reported price
$28.52 / derivative unit
Traded September 30, 2026Filed October 1, 2026SEC filing
Award disclosed

Mortimer J. Buckley

Director

Phantom Stock Units

Derivative security · not the ordinary share price.

Value context
$37.5K
Reported price
$28.67 / derivative unit
Traded September 25, 2026Filed September 29, 2026SEC filing
Award disclosed

Joseph Echevarria

Director

Phantom Stock Units

Derivative security · not the ordinary share price.

Value context
$46.25K
Reported price
$28.67 / derivative unit
Traded September 25, 2026Filed September 29, 2026SEC filing
Award disclosed

Shantanu Narayen

Director

Phantom Stock Units

Derivative security · not the ordinary share price.

Value context
$50K
Reported price
$28.67 / derivative unit
Traded September 25, 2026Filed September 29, 2026SEC filing
Award disclosed

James Quincey

Director

Phantom Stock Units

Derivative security · not the ordinary share price.

Value context
$38.75K
Reported price
$28.67 / derivative unit
Traded September 25, 2026Filed September 29, 2026SEC filing
Award disclosed

James C. Smith

Director

Phantom Stock Units

Derivative security · not the ordinary share price.

Value context
$45K
Reported price
$28.67 / derivative unit
Traded September 25, 2026Filed September 29, 2026SEC filing
Award disclosed

Cyrus Taraporevala

Director

Phantom Stock Units

Derivative security · not the ordinary share price.

Value context
$37.5K
Reported price
$28.67 / derivative unit
Traded September 25, 2026Filed September 29, 2026SEC filing
Award disclosed

Albert Bourla

Chairman & CEO

Phantom Stock Units SSP

Derivative security · not the ordinary share price.

Value context
$606.1
Reported price
$27.55 / derivative unit
Traded September 15, 2026Filed September 16, 2026SEC filing
Award disclosed

Albert Bourla

Chairman & CEO

Phantom Stock Units SSP

Derivative security · not the ordinary share price.

Value context
$597.66
Reported price
$28.46 / derivative unit
Traded August 31, 2026Filed September 1, 2026SEC filing
Award disclosed

Albert Bourla

Chairman & CEO

Phantom Stock Units SSP

Derivative security · not the ordinary share price.

Value context
$589.38
Reported price
$26.79 / derivative unit
Traded August 14, 2026Filed August 17, 2026SEC filing
Award disclosed

Albert Bourla

Chairman & CEO

Phantom Stock Units SSP

Derivative security · not the ordinary share price.

Value context
$600.24
Reported price
$25.01 / derivative unit
Traded July 31, 2026Filed August 3, 2026SEC filing
Award disclosed

Albert Bourla

Chairman & CEO

Phantom Stock Units SSP

Derivative security · not the ordinary share price.

Value context
$595.68
Reported price
$24.82 / derivative unit
Traded July 15, 2026Filed July 16, 2026SEC filing
Award disclosed

Albert Bourla

Chairman & CEO

Phantom Stock Units SSP

Derivative security · not the ordinary share price.

Value context
$2.04K
Reported price
$24.25 / derivative unit
Traded July 9, 2026Filed July 13, 2026SEC filing
Award disclosed

Albert Bourla

Chairman & CEO

Phantom Stock Units SSP

Derivative security · not the ordinary share price.

Value context
$602
Reported price
$24.08 / derivative unit
Traded June 30, 2026Filed July 1, 2026SEC filing
Award disclosed

Mortimer J. Buckley

Director

Phantom Stock Units

Derivative security · not the ordinary share price.

Value context
$37.5K
Reported price
$24.29 / derivative unit
Traded June 26, 2026Filed June 30, 2026SEC filing
Award disclosed

Joseph Echevarria

Director

Phantom Stock Units

Derivative security · not the ordinary share price.

Value context
$46.25K
Reported price
$24.29 / derivative unit
Traded June 26, 2026Filed June 30, 2026SEC filing
Award disclosed

Shantanu Narayen

Director

Phantom Stock Units

Derivative security · not the ordinary share price.

Value context
$50K
Reported price
$24.29 / derivative unit
Traded June 26, 2026Filed June 30, 2026SEC filing
Award disclosed

James C. Smith

Director

Phantom Stock Units

Derivative security · not the ordinary share price.

Value context
$45K
Reported price
$24.29 / derivative unit
Traded June 26, 2026Filed June 30, 2026SEC filing
Award disclosed

James Quincey

Director

Phantom Stock Units

Derivative security · not the ordinary share price.

Value context
$38.75K
Reported price
$24.29 / derivative unit
Traded June 26, 2026Filed June 30, 2026SEC filing
Award disclosed

Cyrus Taraporevala

Director

Phantom Stock Units

Derivative security · not the ordinary share price.

Value context
$37.5K
Reported price
$24.29 / derivative unit
Traded June 26, 2026Filed June 30, 2026SEC filing
Reporting insiderSecurity / transactionAmount / priceValueTraded / disclosedSource
Chairman & CEOPhantom Stock Units SSPGrant or awardDerivative units21$28.52 / derivative unit$598.92Sep 30Filed Oct 1 · 1d laterSEC filing
DirectorPhantom Stock UnitsGrant or awardDerivative units1,308$28.67 / derivative unit$37.5KSep 25Filed Sep 29 · 4d laterSEC filing
DirectorPhantom Stock UnitsGrant or awardDerivative units1,613$28.67 / derivative unit$46.25KSep 25Filed Sep 29 · 4d laterSEC filing
DirectorPhantom Stock UnitsGrant or awardDerivative units1,744$28.67 / derivative unit$50KSep 25Filed Sep 29 · 4d laterSEC filing
DirectorPhantom Stock UnitsGrant or awardDerivative units1,352$28.67 / derivative unit$38.75KSep 25Filed Sep 29 · 4d laterSEC filing
DirectorPhantom Stock UnitsGrant or awardDerivative units1,570$28.67 / derivative unit$45KSep 25Filed Sep 29 · 4d laterSEC filing
DirectorPhantom Stock UnitsGrant or awardDerivative units1,308$28.67 / derivative unit$37.5KSep 25Filed Sep 29 · 4d laterSEC filing
Chairman & CEOPhantom Stock Units SSPGrant or awardDerivative units22$27.55 / derivative unit$606.1Sep 15Filed Sep 16 · 1d laterSEC filing
Chairman & CEOPhantom Stock Units SSPGrant or awardDerivative units21$28.46 / derivative unit$597.66Aug 31Filed Sep 1 · 1d laterSEC filing
Chairman & CEOPhantom Stock Units SSPGrant or awardDerivative units22$26.79 / derivative unit$589.38Aug 14Filed Aug 17 · 3d laterSEC filing
Chairman & CEOPhantom Stock Units SSPGrant or awardDerivative units24$25.01 / derivative unit$600.24Jul 31Filed Aug 3 · 3d laterSEC filing
Chairman & CEOPhantom Stock Units SSPGrant or awardDerivative units24$24.82 / derivative unit$595.68Jul 15Filed Jul 16 · 1d laterSEC filing
Chairman & CEOPhantom Stock Units SSPGrant or awardDerivative units84$24.25 / derivative unit$2.04KJul 9Filed Jul 13 · 4d laterSEC filing
Chairman & CEOPhantom Stock Units SSPGrant or awardDerivative units25$24.08 / derivative unit$602Jun 30Filed Jul 1 · 1d laterSEC filing
DirectorPhantom Stock UnitsGrant or awardDerivative units1,544$24.29 / derivative unit$37.5KJun 26Filed Jun 30 · 4d laterSEC filing
DirectorPhantom Stock UnitsGrant or awardDerivative units1,904$24.29 / derivative unit$46.25KJun 26Filed Jun 30 · 4d laterSEC filing
DirectorPhantom Stock UnitsGrant or awardDerivative units2,058$24.29 / derivative unit$50KJun 26Filed Jun 30 · 4d laterSEC filing
DirectorPhantom Stock UnitsGrant or awardDerivative units1,853$24.29 / derivative unit$45KJun 26Filed Jun 30 · 4d laterSEC filing
DirectorPhantom Stock UnitsGrant or awardDerivative units1,595$24.29 / derivative unit$38.75KJun 26Filed Jun 30 · 4d laterSEC filing
DirectorPhantom Stock UnitsGrant or awardDerivative units1,544$24.29 / derivative unit$37.5KJun 26Filed Jun 30 · 4d laterSEC filing

Showing the latest 20 of 44 trades. Show all 44 trades

Congress transactions 11

All Congress filings
Sale disclosedAmended report

Pfizer, Inc. Common Stock (PFE) · Stock

The filing reports a sale for a spouse.

Carol Devine Miller official portraitCarol Devine MillerReporting House member
Reported amount
$15,001 – $50,000Reported range; exact amount not disclosed.
Trade date
March 10, 2025
Filed August 13, 2026 · 521d laterOriginal report
Sale disclosed

Pfizer, Inc. Common Stock (PFE) · Stock

The filing reports a sale for the member.

Michael Rulli official portraitMichael RulliReporting House member
Reported amount
$1,001 – $15,000Reported range; exact amount not disclosed.
Trade date
November 26, 2024
Filed August 7, 2026 · 619d laterOriginal report
Full sale disclosedAmended report

Pfizer, Inc. Common Stock · Stock

The filing reports a full sale for a joint account.

Thomas H Tuberville official portraitThomas H TubervilleReporting Senate member
Reported amount
$15,001 – $50,000Reported range; exact amount not disclosed.
Trade date
May 3, 2024
Filed August 5, 2026 · 824d laterOriginal report
Full sale disclosed

Pfizer, Inc. Common Stock · Stock

The filing reports a full sale for the member.

AAAlan ArmstrongReporting Senate member
Reported amount
$50,001 – $100,000Reported range; exact amount not disclosed.
Trade date
March 24, 2026
Filed July 21, 2026 · 119d laterOriginal report
Full sale disclosed

Pfizer, Inc. Common Stock · Stock

The filing reports a full sale for a joint account.

Thomas H Tuberville official portraitThomas H TubervilleReporting Senate member
Reported amount
$15,001 – $50,000Reported range; exact amount not disclosed.
Trade date
June 8, 2026
Filed July 16, 2026 · 38d laterOriginal report
Partial sale disclosed

Pfizer, Inc. Common Stock (PFE) · Stock

The filing reports a partial sale for the member.

Gilbert Cisneros official portraitGilbert CisnerosReporting House member
Reported amount
$1,001 – $15,000Reported range; exact amount not disclosed.
Trade date
March 13, 2026
Filed April 7, 2026 · 25d laterOriginal report
Purchase disclosed

Pfizer, Inc. Common Stock (PFE) · Stock

The filing reports a purchase for the member.

Gilbert Cisneros official portraitGilbert CisnerosReporting House member
Reported amount
$1,001 – $15,000Reported range; exact amount not disclosed.
Trade date
February 10, 2026
Filed March 9, 2026 · 27d laterOriginal report
Sale disclosed

Pfizer, Inc. Common Stock (PFE) · Stock

The filing reports a sale for the member.

James French Hill official portraitJames French HillReporting House member
Reported amount
$100,001 – $250,000Reported range; exact amount not disclosed.
Trade date
December 31, 2025
Filed January 23, 2026 · 23d laterOriginal report
Purchase disclosed

Pfizer, Inc. Common Stock (PFE) · Stock

The filing reports a purchase for the member.

Julia Letlow official portraitJulia LetlowReporting House member
Reported amount
$1,001 – $15,000Reported range; exact amount not disclosed.
Trade date
June 17, 2025
Filed January 13, 2026 · 210d laterOriginal report
Partial sale disclosed

Pfizer, Inc. Common Stock (PFE) · Stock

The filing reports a partial sale for the member.

Gilbert Cisneros official portraitGilbert CisnerosReporting House member
Reported amount
$1,001 – $15,000Reported range; exact amount not disclosed.
Trade date
December 19, 2025
Filed January 12, 2026 · 24d laterOriginal report
Purchase disclosed

Pfizer, Inc. Common Stock (PFE) · Stock

The filing reports a purchase for the member.

Gilbert Cisneros official portraitGilbert CisnerosReporting House member
Reported amount
$1,001 – $15,000Reported range; exact amount not disclosed.
Trade date
November 18, 2025
Filed December 15, 2025 · 27d laterOriginal report
Explore furtherTechnical lab Company financials Test a strategy Compare company

Why this buying score?

Qualifying common-equity purchase value

$1,828,244 of common-equity purchase value after transaction-age decay across 180 days.

+25 pts

Distinct buying groups

3 distinct reporting-owner group(s). Joint rows count once; identity is not proof of discretion.

+13 pts

CEO purchase

Qualifying common-equity P acquisition; no disclosed plan, exercise or excluded purchase context detected.

+11 pts

Material reported holdings increase

At least one row increased reported same-security holdings by 10% or established a new reported position; indirect interests may overlap.

+6 pts

This score describes qualifying insider purchases at issuer level. Read the methodology

Sources and coverage

Limited filing history · Market-wide discovery does not establish complete company history. View coverage
Source
SEC EDGAR · Form 4
Issuer CIK
0000078003
Latest public acceptance
Oct 1, 2026, 06:04 PM UTC
Score calculated
Oct 7, 2026, 12:04 AM UTC
Parser
form4-parser-1.5
Classifier
form4-classifier-1.1
Scoring methodology
insider-experimental-1.1
Availability
Public filing time, not trade date

Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.

Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.